Insights

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an...

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress...

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous...

Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00...

NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare...

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending...

PTC Therapeutics, Inc. today announced a corporate update and reported financial results for the second quarter ended June 30, 2014....

-- Third quarter revenue of $398 million declined 6 percent versus prior year -- Adjusted diluted earnings per share for...

Therapath LLC (www.Therapath.com),a leader in neuropathology laboratory services, has established normative values for two upper limb body sites that can...